Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | glycylpeptide N-tetradecanoyltransferase | 0.1059 | 0.3809 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0142 | 0.0337 | 0.0857 |
Echinococcus multilocularis | neuroendocrine convertase 2 | 0.0089 | 0.0138 | 0.0256 |
Echinococcus multilocularis | integrin alpha ps | 0.0132 | 0.0302 | 0.0692 |
Brugia malayi | Integrin beta pat-3 precursor | 0.0303 | 0.0946 | 0.2358 |
Loa Loa (eye worm) | hypothetical protein | 0.0232 | 0.0679 | 0.1757 |
Loa Loa (eye worm) | integrin beta-2 | 0.0303 | 0.0946 | 0.2461 |
Brugia malayi | endoprotease bli-4 precursor | 0.0142 | 0.0337 | 0.0733 |
Toxoplasma gondii | aspartyl proteinase (eimepsin), putative | 0.01 | 0.018 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 0.0041 | 0.0079 |
Brugia malayi | celfurPC protein | 0.0114 | 0.0233 | 0.0456 |
Schistosoma mansoni | family A2 unassigned peptidase (A02 family) | 0.049 | 0.1655 | 0.1627 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0296 | 0.092 | 0.0889 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.01 | 0.018 | 0.0147 |
Trypanosoma brucei | N-myristoyltransferase | 0.1059 | 0.3809 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0063 | 0.0041 | 0.0007 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.1059 | 0.3809 | 0.5 |
Brugia malayi | proprotein convertase 2 | 0.0089 | 0.0138 | 0.0202 |
Schistosoma mansoni | integrin alpha-ps | 0.0132 | 0.0302 | 0.0269 |
Schistosoma mansoni | integrin alpha-ps | 0.0069 | 0.0062 | 0.0028 |
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.0062 | 0.0134 |
Trichomonas vaginalis | N-myristoyl transferase, putative | 0.1059 | 0.3809 | 1 |
Leishmania major | N-myristoyl transferase, putative | 0.1059 | 0.3809 | 0.5 |
Schistosoma mansoni | integrin beta subunit | 0.0178 | 0.0475 | 0.0443 |
Echinococcus multilocularis | proprotein convertase subtilisin:kexin type 5 | 0.0086 | 0.0127 | 0.0227 |
Loa Loa (eye worm) | hypothetical protein | 0.0223 | 0.0646 | 0.1673 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.1059 | 0.3809 | 0.5 |
Brugia malayi | Integrin alpha pat-2 precursor | 0.0295 | 0.0919 | 0.2286 |
Echinococcus granulosus | integrin alpha ps | 0.0132 | 0.0302 | 0.0692 |
Echinococcus granulosus | neuroendocrine convertase 2 | 0.0089 | 0.0138 | 0.0256 |
Echinococcus multilocularis | integrin beta 2 | 0.0224 | 0.0649 | 0.1613 |
Echinococcus granulosus | integrin beta 2 | 0.0224 | 0.0649 | 0.1613 |
Echinococcus granulosus | proprotein convertase subtilisin:kexin type 5 | 0.0086 | 0.0127 | 0.0227 |
Echinococcus multilocularis | integrin alpha ps | 0.0132 | 0.0302 | 0.0692 |
Echinococcus granulosus | glycylpeptide N tetradecanoyltransferase | 0.1059 | 0.3809 | 1 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0296 | 0.092 | 0.0889 |
Loa Loa (eye worm) | hypothetical protein | 0.0163 | 0.0418 | 0.107 |
Giardia lamblia | CDC72 | 0.1059 | 0.3809 | 1 |
Echinococcus multilocularis | 0.0114 | 0.0233 | 0.051 | |
Schistosoma mansoni | subfamily S8B unassigned peptidase (S08 family) | 0.0142 | 0.0337 | 0.0304 |
Loa Loa (eye worm) | endoprotease bli-4 | 0.0142 | 0.0337 | 0.0857 |
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.0062 | 0.0134 |
Echinococcus granulosus | cathepsin d lysosomal aspartyl protease | 0.01 | 0.018 | 0.0369 |
Plasmodium vivax | glycylpeptide N-tetradecanoyltransferase, putative | 0.1059 | 0.3809 | 1 |
Echinococcus multilocularis | glycylpeptide N tetradecanoyltransferase | 0.1059 | 0.3809 | 1 |
Echinococcus multilocularis | integrin alpha 3 | 0.0226 | 0.0658 | 0.1637 |
Trichomonas vaginalis | N-myristoyl transferase, putative | 0.0696 | 0.2435 | 0.6267 |
Loa Loa (eye worm) | DEAH box polypeptide 35 | 0.0069 | 0.0062 | 0.0134 |
Entamoeba histolytica | glycylpeptide N-tetradecanoyltransferase, putative | 0.1059 | 0.3809 | 0.5 |
Schistosoma mansoni | N-myristoyltransferase | 0.1059 | 0.3809 | 0.3788 |
Brugia malayi | neuroendocrine convertase 1 precursor | 0.0089 | 0.0138 | 0.0202 |
Trypanosoma brucei | N-myristoyl transferase, putative | 0.1059 | 0.3809 | 0.5 |
Brugia malayi | Integrin alpha cytoplasmic region family protein | 0.0223 | 0.0646 | 0.156 |
Trichomonas vaginalis | Clan AA, family A1, cathepsin D-like aspartic peptidase | 0.01 | 0.018 | 0.0146 |
Echinococcus multilocularis | cathepsin d (lysosomal aspartyl protease) | 0.01 | 0.018 | 0.0369 |
Schistosoma mansoni | integrin alpha | 0.0295 | 0.0919 | 0.0888 |
Brugia malayi | N-myristoyltransferase 2 | 0.1059 | 0.3809 | 1 |
Brugia malayi | Angiotensin-converting enzyme family protein | 0.0607 | 0.2096 | 0.5427 |
Loa Loa (eye worm) | aspartic protease BmAsp-2 | 0.01 | 0.018 | 0.0446 |
Toxoplasma gondii | aspartyl protease ASP1 | 0.01 | 0.018 | 0.5 |
Echinococcus granulosus | integrin alpha 3 | 0.0226 | 0.0658 | 0.1637 |
Loa Loa (eye worm) | N-myristoyltransferase 2 | 0.1059 | 0.3809 | 1 |
Loa Loa (eye worm) | angiotensin-converting enzyme family protein | 0.0607 | 0.2096 | 0.5488 |
Echinococcus granulosus | furin | 0.0142 | 0.0337 | 0.0785 |
Loa Loa (eye worm) | integrin alpha pat-2 | 0.0455 | 0.1524 | 0.3983 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.018 | 0.0446 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 2 ug ml-1 | Inhibitory concentration required against human chronic myelogenous leukemic K-562 cell line after 48h, using [3H]-thymidine incorporationassay | ChEMBL. | 12617912 |
IC50 (functional) | = 2 ug ml-1 | Inhibitory concentration required against human chronic myelogenous leukemic K-562 cell line after 48h, using [3H]-thymidine incorporationassay | ChEMBL. | 12617912 |
IC50 (functional) | = 6 ug ml-1 | Inhibitory concentration required against human chronic myelogenous leukemic K-562 cell line after 5h, using [3H]-thymidine incorporationassay | ChEMBL. | 12617912 |
IC50 (functional) | = 6 ug ml-1 | Inhibitory concentration required against human chronic myelogenous leukemic K-562 cell line after 5h, using [3H]-thymidine incorporationassay | ChEMBL. | 12617912 |
IC50 (functional) | = 8.3 ug ml-1 | Compound was tested for its cytotoxicity in VERO cells (at concentration less than or equal to 62.5 ug/mL or 10 times the MIC for M. tuberculosis H37Rv) | ChEMBL. | 10866382 |
Inhibition (functional) | = 98 % | Inhibitory activity (at 12.5 microg/mL) against Mycobacterium tuberculosis H37Rv in BACTEC 12B medium using the Microplate Alamar Blue Assay | ChEMBL. | 10866382 |
Inhibition (functional) | = 98 % | Inhibitory activity (at 12.5 microg/mL) against Mycobacterium tuberculosis H37Rv in BACTEC 12B medium using the Microplate Alamar Blue Assay | ChEMBL. | 10866382 |
Inhibition (functional) | = 99 % | Percent inhibition of [3H]-thymidine incorporation was determined in human chronic myelogenous leukemic K-562 cell line at 10 microg/mL after 48 hr | ChEMBL. | 12617912 |
Inhibition (functional) | = 99 % | Percent inhibition of [3H]-thymidine incorporation was determined in human chronic myelogenous leukemic K-562 cell line at 10 microg/mL after 48 hr | ChEMBL. | 12617912 |
MIC (functional) | > 6.25 ug ml-1 | Minimum inhibitory concentration against Mycobacterium tuberculosis H37Rv in BACTEC 12B medium using the Microplate Alamar Blue Assay | ChEMBL. | 10866382 |
MIC (functional) | > 6.25 ug ml-1 | Minimum inhibitory concentration against Mycobacterium tuberculosis H37Rv in BACTEC 12B medium using the Microplate Alamar Blue Assay | ChEMBL. | 10866382 |
SI (functional) | < 1.3 | Selectivity index was determined by taking ratio of IC50 to that of MIC | ChEMBL. | 10866382 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 12617912 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.